Deep Parasternal Intercostal Plane Block Versus Erector Spinae Plane Block in Pediatric Cardiac Patients Undergoing Primary Repair of Septal Defects Via Median Sternotomy
Launched by AIN SHAMS UNIVERSITY · Mar 7, 2025
Trial Information
Current as of May 09, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating two different techniques for managing pain in young patients who are having surgery to repair septal defects in their hearts. Specifically, the study compares the Deep Parasternal Intercostal Plane Block and the Erector Spinae Plane Block to find out which method is more effective for helping children feel comfortable after their surgery. The researchers will look at how long it takes for patients to ask for pain relief, how much pain medication they need, and whether they experience any side effects like nausea or difficulty moving after the procedure.
To participate in this study, children aged 1 to 10 years who have a specific type of heart condition called an acyanotic septal defect may be eligible. However, some children may not qualify if they have certain health issues, allergies to pain medications, or if their guardians do not want them to take part. Participants will be placed into one of three groups: one group will receive the first pain management technique, another group will receive the second technique, and the third group will follow a standard approach without the specialized blocks. This trial aims to ensure that children have the best possible care and comfort during their recovery after heart surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Pediatric patients with acyanotic heart disease
- • Patients with septal defect undergoing primary repair
- • ASA Ⅰ and Ⅱ
- Exclusion Criteria:
- • Patient's guardian refusal of procedure or participation in the study.
- • Patients with hemodynamic instability
- • Preexisting infection at the block site
- • Allergy to local anesthetics
- • Psychiatric illness
- • Abnormal coagulation profile
- • Preoperative ejection fraction less than 35%
- • Recurrent ventricular arrhythmias
- • Emergency Surgery
- • Redo surgeries
About Ain Shams University
Ain Shams University, established in Cairo, Egypt, is a prestigious higher education institution renowned for its commitment to academic excellence and research innovation. As a clinical trial sponsor, the university leverages its extensive resources and expertise in various medical and scientific disciplines to advance healthcare through rigorous research initiatives. With a focus on ethical practices and adherence to regulatory standards, Ain Shams University aims to contribute to the development of new therapies and improve patient outcomes, fostering collaboration among researchers, healthcare professionals, and industry partners in the pursuit of medical advancements.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Cairo, , Egypt
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported